A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up

N/ACompletedNCT04208139

NC Heart and Vascular Research, LLC11 enrolled

Overview

IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up

Study Type

OBSERVATIONAL

Enrollment

Conditions

Recurrent Pulmonary Embolism (Disorder)

Interventions

IVUSDIAGNOSTIC_TEST

IVUS

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age * Signed the informed consent document * Participants from the SENTRY clinical trial willing to undergo one time IVUS evaluation ( outpatient ) Exclusion Criteria: * Any filter that remained non converted.

Locations (1)

NC Heart and Vascular Research, LLC

Raleigh, North Carolina, United States

Outcomes

Primary Outcomes

Patency of the inferior vena cava

Time frame: 3-5 years

Cylindrical frame integrity

Time frame: 3-5 years

Impact of the Sentry cylindrical frame on the vessel wall evaluation for endothelialization and neointimal hyperplasia and wall dynamics

Time frame: 3-5 years

Presence and characterization of adherent thrombus

Time frame: 3-5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.